Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Current Assets (2021 - 2025)

LifeStance Health (LFST) has disclosed Current Assets for 5 consecutive years, with $416.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Current Assets rose 33.18% to $416.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $416.2 million, a 33.18% increase, with the full-year FY2025 number at $416.2 million, up 33.18% from a year prior.
  • Current Assets was $416.2 million for Q4 2025 at LifeStance Health, up from $360.4 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $416.2 million in Q4 2025 to a low of $212.5 million in Q1 2023.
  • A 5-year average of $287.1 million and a median of $266.5 million in 2021 define the central range for Current Assets.
  • Peak YoY movement for Current Assets: crashed 32.9% in 2022, then skyrocketed 38.44% in 2024.
  • LifeStance Health's Current Assets stood at $266.5 million in 2021, then dropped by 12.49% to $233.2 million in 2022, then dropped by 3.21% to $225.7 million in 2023, then surged by 38.44% to $312.5 million in 2024, then skyrocketed by 33.18% to $416.2 million in 2025.
  • Per Business Quant, the three most recent readings for LFST's Current Assets are $416.2 million (Q4 2025), $360.4 million (Q3 2025), and $358.8 million (Q2 2025).